^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
PredicineCNB™

Company:
Predicine
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
PredicineCNB is a companion LP-WGS assay to robustly estimate genome-wide copy number burden (CNB) from plasma and urine clinical samples, which can provide longitudinal disease monitoring in a cost-effective way. A comprehensive clinical study using PredicineCNB in 1,000 patients with prostate and bladder cancers demonstrated the promising clinical application of liquid biopsy-based genome-wide copy number changes in therapy monitoring.
Cancer:
Bladder Cancer, Prostate Cancer
Method:
Low-pass whole-genome sequencing